SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/11/1/20.09.24

SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/11/1/20.09.24 Stock

DE000SQ3G7Z5

Delayed Deutsche Boerse AG 03:41:37 2024-07-05 pm EDT
5.18 ^EUR	+0.78%

Current month	+2.57%
1 month	-7.66%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/11/1/20.09.24

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024	Jul. 02	BU
Sector Update: Health Care Stocks Retreat Late Afternoon	Jul. 01	MT
Sector Update: Health Care Stocks Slipping in Afternoon Trading	Jul. 01	MT
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	Jul. 01	MT

More news

Quotes 5-day view

Date	Price	Change
24-07-05	5.18	+0.78%
24-07-04	5.14	-0.96%
24-07-03	5.19	-3.35%
24-07-02	5.37	+4.68%
24-07-01	5.13	+1.58%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 03:41 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Société Générale
WKN	SQ3G7Z
ISIN	DE000SQ3G7Z5
Date issued	2022-10-27
Strike	11 $
Maturity	2024-09-20 (75 Days)
Parity	1 : 1
Emission price	1.97 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	6.3 €
Lowest since issue	0.65 €
Spread	0.74 €
Spread %	13.31%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.4 USD

Average target price

18.74 USD

Spread / Average Target

+14.24%

Consensus